S R Ytterberg
Affiliation: Mayo Clinic
- Viral arthritisS R Ytterberg
Division of Rheumatology, Mayo Clinic, Rochester, MN 55905, USA
Curr Opin Rheumatol 11:275-80. 1999..Studies of rheumatic syndromes associated with other viral infections, including alphaviruses, rubella, hepatitis C, and retroviruses, suggest differing mechanisms of host interaction with the infectious agents to cause disease...
- Treatment of refractory polymyositis and dermatomyositisSteven R Ytterberg
Division of Rheumatology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
Curr Rheumatol Rep 8:167-73. 2006..Better understanding of the underlying pathophysiology of PM and DM, as well as carefully performed multicenter clinical trials is going to be necessary to make better recommendations in the future...
- Vasculitis working group: selected unanswered questions related to giant cell arteritis and anti-neutrophil cytoplasmic antibody-associated vasculitisSteven R Ytterberg
Rheumatology Division, Mayo Clinic, Rochester, MN, USA
Joint Bone Spine 76:440-3. 2009..Collectively, this review shows that more research is needed to provide a firmer body of evidence to support clinical decision-making for patients with vasculitis...
- Clinical features of 39 patients with antibodies to extractable nuclear antigens despite negative antinuclear antibodies: evidence for autoimmunity including neurologic and connective tissue diseasesJohn M Davis
Division of Rheumatology, Department of Medicine, Mayo Clinic College of Medicine and Mayo Clinic, Rochester, Minnesota 55905, USA
Medicine (Baltimore) 84:208-17. 2005..This may represent test bias or false-positive anti-ENA assays or false-negative ANA assays, or may imply immune-related mechanisms not previously described...
- Genetic and environmental risk factors for idiopathic inflammatory myopathiesAnn M Reed
Division of Pediatric Rheumatology, Departments of Pediatrics and Internal Medicine, Mayo Clinic Rochester, Mayo Medical School, 200 First Street SW, Rochester, MN 55905, USA
Rheum Dis Clin North Am 28:891-916. 2002....
- Epidemiology of sporadic inclusion body myositis and polymyositis in Olmsted County, MinnesotaFloranne C Wilson
Division of Rheumatology, Mayo Clinic, College of Medicine, Rochester, Minnesota 55905, USA
J Rheumatol 35:445-7. 2008..To determine the incidence and prevalence of sporadic inclusion body myositis (sIBM) and polymyositis (PM) in a population-based study...
- Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET)Philip Seo
Johns Hopkins University, Baltimore, Maryland
Arthritis Rheum 52:2168-78. 2005..To analyze damage occurring in patients with Wegener's granulomatosis (WG) enrolled in the WG Etanercept Trial (WGET) and to correlate that damage with disease activity, adverse events, and quality of life...
- Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trialKarina A Keogh
Division of Pulmonary and Critical Care Medicine, Mayo Clinic and Foundation, 200 First Street SW, Rochester, MN 55905, USA
Am J Respir Crit Care Med 173:180-7. 2006..Their depletion has been proposed as salvage therapy for refractory disease. Earlier encouraging reports are confounded by concomitant immunosuppressive medications and include only limited available biomarker data...
- 61-year-old man with dyspnea and bilateral foot dropLee D Cranmer
Mayo Graduate School of Medicine, Mayo Clinic, Rochester, Minn 55905, USA
Mayo Clin Proc 77:363-6. 2002
- 37-year-old woman with headacheNicole M Orzechowski
Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
Mayo Clin Proc 81:1393-6. 2006
- An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activityEmily C Baechler
University of Minnesota Medical School, Minneapolis, MN 55455, USA
Mol Med 13:59-68. 2007..These data suggest that the IFN signature may be a useful marker for DM disease activity, and that sampling peripheral blood may be a more practical alternative to muscle biopsy for measuring this signature...
- Herpes zoster in immunocompromised patients: incidence, timing, and risk factorsPeter K Wung
Johns Hopkins University School of Medicine, Johns Hopkins University, Baltimore, MD, USA
Am J Med 118:1416. 2005..To evaluate the risk factors for herpes zoster as well as the incidence and timing of this complication in patients who were treated with immunosuppression because of active Wegener's granulomatosis...